These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 36431906)
1. The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential. Nistor G; Mioc M; Mioc A; Balan-Porcarasu M; Racoviceanu R; Prodea A; Milan A; Ghiulai R; Semenescu A; Dehelean C; Șoica C Molecules; 2022 Nov; 27(22):. PubMed ID: 36431906 [TBL] [Abstract][Full Text] [Related]
2. A novel triazole derivative of betulinic acid induces extrinsic and intrinsic apoptosis in human leukemia HL-60 cells. Khan I; Guru SK; Rath SK; Chinthakindi PK; Singh B; Koul S; Bhushan S; Sangwan PL Eur J Med Chem; 2016 Jan; 108():104-116. PubMed ID: 26629862 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry. Shi W; Tang N; Yan WD J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995 [TBL] [Abstract][Full Text] [Related]
4. Novel Triterpenic Acid-Benzotriazole Esters Act as Pro-Apoptotic Antimelanoma Agents. Mioc M; Mioc A; Prodea A; Milan A; Balan-Porcarasu M; Racoviceanu R; Ghiulai R; Iovanescu G; Macasoi I; Draghici G; Dehelean C; Soica C Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077389 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of 3-O-propargylated betulinic acid and its 1,2,3-triazoles as potential apoptotic agents. Majeed R; Sangwan PL; Chinthakindi PK; Khan I; Dangroo NA; Thota N; Hamid A; Sharma PR; Saxena AK; Koul S Eur J Med Chem; 2013 May; 63():782-92. PubMed ID: 23584541 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment. Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a novel betulinic acid derivative as an inducer of apoptosis in human colon carcinoma cells (HT-29). Chakraborty B; Dutta D; Mukherjee S; Das S; Maiti NC; Das P; Chowdhury C Eur J Med Chem; 2015 Sep; 102():93-105. PubMed ID: 26248310 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia. Waechter F; da Silva GNS; Willig JB; de Oliveira CB; Vieira BD; Trivella DBB; Zimmer AR; Buffon A; Pilger DA; Gnoatto SCB Anticancer Agents Med Chem; 2017; 17(13):1777-1785. PubMed ID: 28403779 [TBL] [Abstract][Full Text] [Related]
10. Preparation of amino acid conjugates of betulinic acid with activity against human melanoma. Jeong HJ; Chai HB; Park SY; Kim DS Bioorg Med Chem Lett; 1999 Apr; 9(8):1201-4. PubMed ID: 10328313 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives. Sidova V; Zoufaly P; Pokorny J; Dzubak P; Hajduch M; Popa I; Urban M PLoS One; 2017; 12(2):e0171621. PubMed ID: 28158265 [TBL] [Abstract][Full Text] [Related]
12. The new esters derivatives of betulin and betulinic acid in epidermoid squamous carcinoma treatment - In vitro studies. Drąg-Zalesińska M; Wysocka T; Borska S; Drąg M; Poręba M; Choromańska A; Kulbacka J; Saczko J Biomed Pharmacother; 2015 May; 72():91-7. PubMed ID: 26054680 [TBL] [Abstract][Full Text] [Related]
13. Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives. Aswathy M; Vijayan A; Daimary UD; Girisa S; Radhakrishnan KV; Kunnumakkara AB J Biochem Mol Toxicol; 2022 Dec; 36(12):e23206. PubMed ID: 36124371 [TBL] [Abstract][Full Text] [Related]
14. PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation. Majeed R; Hussain A; Sangwan PL; Chinthakindi PK; Khan I; Sharma PR; Koul S; Saxena AK; Hamid A Mol Carcinog; 2016 May; 55(5):964-76. PubMed ID: 26013878 [TBL] [Abstract][Full Text] [Related]
15. Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives. Fernandes S; Vieira M; Prudêncio C; Ferraz R Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396785 [TBL] [Abstract][Full Text] [Related]
17. In vitro anticancer activity of Betulinic acid and derivatives thereof on equine melanoma cell lines from grey horses and in vivo safety assessment of the compound NVX-207 in two horses. Liebscher G; Vanchangiri K; Mueller T; Feige K; Cavalleri JM; Paschke R Chem Biol Interact; 2016 Feb; 246():20-9. PubMed ID: 26772157 [TBL] [Abstract][Full Text] [Related]
18. Substituted dienes prepared from betulinic acid - Synthesis, cytotoxicity, mechanism of action, and pharmacological parameters. Pokorný J; Olejníková D; Frydrych I; Lišková B; Gurská S; Benická S; Šarek J; Kotulová J; Hajdúch M; Džubák P; Urban M Eur J Med Chem; 2021 Nov; 224():113706. PubMed ID: 34311159 [TBL] [Abstract][Full Text] [Related]
19. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line. Liu WK; Ho JC; Cheung FW; Liu BP; Ye WC; Che CT Eur J Pharmacol; 2004 Sep; 498(1-3):71-8. PubMed ID: 15363977 [TBL] [Abstract][Full Text] [Related]
20. The Antimelanoma Biological Assessment of Triterpenic Acid Functionalized Gold Nanoparticles. Mioc M; Mioc A; Racoviceanu R; Ghiulai R; Prodea A; Milan A; Barbu Tudoran L; Oprean C; Ivan V; Șoica C Molecules; 2023 Jan; 28(1):. PubMed ID: 36615613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]